SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis

H Fang, Y Huang, Y Luo, J Tang, M Yu, Y Zhang… - Cellular …, 2022 - Elsevier
Our previous work suggested that high SIRT1 expression by cancer cells predicted a poor
colorectal cancer (CRC) prognosis, but its role in the tumor microenvironment was unclear …

[HTML][HTML] High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients

X Chen, K Sun, S Jiao, N Cai, X Zhao, H Zou, Y Xie… - Scientific reports, 2014 - nature.com
SIRT1, a NAD+ dependent class III deacetylase, takes part in many important biological
processes. Previous studies show that SIRT1 is overexpressed in some cancers and plays …

SIRT5 contributes to colorectal cancer growth by regulating T cell activity

K Wang, Z Hu, C Zhang, L Yang, L Feng… - Journal of …, 2020 - Wiley Online Library
Over the past several years, SIRT5 has attracted considerable attention in metabolic
regulation. However, the function of SIRT5 in tumorigenesis by regulating tumor …

[HTML][HTML] SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages

Z Li, H Li, ZB Zhao, W Zhu, PP Feng, XW Zhu… - Journal of Experimental …, 2019 - Springer
Background The activation of tumour-associated macrophages (TAMs) contributes to the
progression of hepatocellular carcinoma (HCC). SIRT4 acts as a tumour suppressor of …

SIRT1 inhibits hepatocellular carcinoma metastasis by promoting M1 macrophage polarization via NF-κB pathway

B Zhou, Y Yang, C Li - OncoTargets and therapy, 2019 - Taylor & Francis
Background Tumor-associated macrophages (TAMs) serve as crucial modulators of the
complicated interaction between cancer cells and immune microenvironment. Sirtuin 1 …

[HTML][HTML] Sirt1-overexpressing mesenchymal stem cells drive the anti-tumor effect through their pro-inflammatory capacity

F Ye, J Jiang, C Zong, X Yang, L Gao, Y Meng, R Li… - Molecular Therapy, 2020 - cell.com
The major obstacles for the efficacy of tumor immunotherapies are their immune-related
systemic adverse events. Therefore, tumor tropism property and pro-inflammatory ability of …

SIRT1 promotes epithelial–mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression

F Cheng, L Su, C Yao, L Liu, J Shen, C Liu, X Chen… - Cancer letters, 2016 - Elsevier
Understanding molecular mechanisms of colorectal cancer (CRC) metastasis is urgently
required for targeted therapy and prognosis of metastatic CRC. In this study, we explored …

Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with Cd47

C Huang, X Wang, Y Wang, Y Feng, X Wang, S Chen… - Nature Cancer, 2024 - nature.com
Immunosuppressive myeloid cells hinder immunotherapeutic efficacy in tumors, but the
precise mechanisms remain undefined. Here, by performing single-cell RNA sequencing in …

[HTML][HTML] Enterocyte-Specific Inactivation of SIRT1 Reduces Tumor Load in the APC+/min Mouse Model

V Leko, GJ Park, U Lao, JA Simon, A Bedalov - PLoS One, 2013 - journals.plos.org
SIRT1 is a mammalian NAD+-dependent histone deacetylase implicated in metabolism,
development, aging and tumorigenesis. Prior studies that examined the effect of enterocyte …

[HTML][HTML] Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis

G Zu, A Ji, T Zhou, N Che - International Journal of Surgery, 2016 - Elsevier
Purpose The relationship between SIRT1 and clinicopathological parameters of colorectal
cancer (CRC) is controversial. To evaluate the clinicopathological and prognostic value of …